Basic Research
Making significant contributions to translational medicine
Research interests in the Department of Pathology can be divided into 5 main groups: development and regeneration, inherent and infectious disease, molecular and cellular immunology, neurological diseases and tumor biology.
Development and Regeneration
Kinji Asahina, PhD–
Liver development, injury, and regeneration.
Cheng-Ming Chuong, MD, PhD–
Development, regeneration, evolution and engineering of ectodermal organogenesis using hair, tooth and feather models.
Inherent and Infectious Disease
Suraiya Rasheed, PhD–
Biomarkers and protein-protein interaction pathways in cancer and viral (HIV) diseases.
Takeshi Saito, MD, PhD–
Pathophysiology of viral hepatitis and liver biology.
Molecular and Cellular Immunology
Lee Ann Baxter-Lowe, PhD, d(ABHI)–
Definition and clinical relevance of HLA polymorphism.
Alan Epstein, MD, PhD–
Development of CAR T-cells for the immunotherapy of solid tumors.
André J. Ouellette, PhD–
Defensins in innate and adaptive immune responses.
Neurological Diseases
David R Hinton, MD, FARVO–
Pathogenesis of age-related macular degeneration and development of novel stem cell and neuroprotective therapies.
Carol Miller, MD–
Cell and molecular biology of neurodegenerative diseases: Translational interfaces with bioengineering.
Tumor Biology
Shahab Azgharzadeh, MD–
Next-Generation Sequencing of Relapsed Neuroblastoma. This study will generate and analyze data from tumor cells obtained from bone marrows of children with relapsed neuroblastoma to identify recurring mutations.
Louis Dubeau, MD, PhD–
Biology, molecular genetics, and animal modeling of ovarian cancer.
Anat Erdreich-Epstein, MD, PhD–
Molecular mechanisms of PID1-based sensitization of brain tumors to chemotherapy in mice.
Joseph Landolph, PhD–
Molecular and cell biology of morphological and neoplastic cell transformation induced by carcinogenic nickel compounds and chromium (VI) compounds.